Literature DB >> 33317907

Stromal POSTN induced by TGF-β1 facilitates the migration and invasion of ovarian cancer.

Huiran Yue1, Wenzhi Li1, Ruifang Chen1, Jieyu Wang1, Xin Lu2, Jun Li3.   

Abstract

OBJECTIVE: Periostin (POSTN) overexpression observed in various cancer types is correlated with metastasis and tumor progression. However, its effect on the crosstalk between ovarian cancer cells and cancer-associated fibroblasts (CAFs) remains elusive. This study aims to ascertain the role of CAF-derived POSTN in the ovarian cancer microenvironment.
METHODS: POSTN expression in high-grade serous ovarian cancer (HGSC) was detected through immunochemistry. Transwell assay was conducted to determine cell migration and invasion. POSTN was knocked down or overexpressed using lentiviral vectors. The potential downstream effects of POSTN were explored and verified by RNA sequencing and western blotting, respectively. In vitro metastatic capability of ovarian cancer cells regulated by POSTN was determined by indirect co-culture.
RESULTS: POSTN was highly enriched in HGSC stromal components, particularly in fibroblasts, while its overexpression was correlated with reduced overall survival (OS). CAF-derived POSTN functioned as a ligand for integrin αvβ3, fueling the migration and invasion of ovarian cancer cells by activating the PI3K/Akt pathway and inducing the epithelial-mesenchymal transition (EMT). Additionally, the pro-metastatic properties and the activation of fibroblasts induced by TGF-β1 partly relied on POSTN.
CONCLUSIONS: Stromal-derived POSTN drives the remodeling of the pro-metastatic microenvironment, which might be as a potential therapeutic target in patients with ovarian cancer.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33317907     DOI: 10.1016/j.ygyno.2020.11.026

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  17 in total

Review 1.  Periostin: an emerging activator of multiple signaling pathways.

Authors:  Zhaoheng Wang; Jiangdong An; Daxue Zhu; Haiwei Chen; Aixin Lin; Jihe Kang; Wenzhao Liu; Xuewen Kang
Journal:  J Cell Commun Signal       Date:  2022-04-12       Impact factor: 5.782

Review 2.  Prognostic utility of the ovarian cancer secretome: a systematic investigation.

Authors:  Pradnya R Kamble; Apoorva Pawar; Ananya A Breed; Grishma Kasle; Bhakti R Pathak
Journal:  Arch Gynecol Obstet       Date:  2022-01-27       Impact factor: 2.493

Review 3.  The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination.

Authors:  Sabrina J Ritch; Carlos M Telleria
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-28       Impact factor: 6.055

4.  Periostin in lymph node pre-metastatic niches governs lymphatic endothelial cell functions and metastatic colonization.

Authors:  Frédéric Kridelka; Agnès Noël; Lionel Gillot; Alizée Lebeau; Louis Baudin; Charles Pottier; Thomas Louis; Tania Durré; Rémi Longuespée; Gabriel Mazzucchelli; Christophe Nizet; Silvia Blacher
Journal:  Cell Mol Life Sci       Date:  2022-05-14       Impact factor: 9.207

5.  Epithelial Stem Cells: Making, Shaping and Breaking the Niche.

Authors:  Paula Ferraces-Riegas; Anona C Galbraith; David P Doupé
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

6.  Extracellular Vesicle Molecular Signatures Characterize Metastatic Dynamicity in Ovarian Cancer.

Authors:  Amber Gonda; Nanxia Zhao; Jay V Shah; Jake N Siebert; Srujanesh Gunda; Berk Inan; Mijung Kwon; Steven K Libutti; Prabhas V Moghe; Nicola L Francis; Vidya Ganapathy
Journal:  Front Oncol       Date:  2021-11-18       Impact factor: 6.244

7.  Clinical Roles of Risk Model Based on Differentially Expressed Genes in Mesenchymal Stem Cells in Prognosis and Immunity of Non-small Cell Lung Cancer.

Authors:  Qiang Guo; Xiao-Yue Xiao; Chuang-Yan Wu; Dan Li; Jiu-Ling Chen; Xiang-Chao Ding; Chao Cheng; Chong-Rui Chen; Song Tong; Si-Hua Wang
Journal:  Front Genet       Date:  2022-02-24       Impact factor: 4.599

8.  miRNAs-mediated overexpression of Periostin is correlated with poor prognosis and immune infiltration in lung squamous cell carcinoma.

Authors:  Xu Bai; Hui Chen; Brian G Oliver
Journal:  Aging (Albany NY)       Date:  2022-05-04       Impact factor: 5.955

9.  Periostin promotes the proliferation and metastasis of osteosarcoma by increasing cell survival and activates the PI3K/Akt pathway.

Authors:  Chaojian Xu; Ziyue Wang; Long Zhang; Yi Feng; Jia Lv; Zhuangzhuang Wu; Rong Yang; Taiyong Wu; Jian Li; Ruhao Zhou; Zhi Tian; Junjun Bai; Huadong Zhang; Yanping Lan; Zhi Lv
Journal:  Cancer Cell Int       Date:  2022-01-20       Impact factor: 5.722

10.  Infiltrating T-cell abundance combined with EMT-related gene expression as a prognostic factor of colon cancer.

Authors:  Xiaowei Huang; Chan Chen; Yajing Xu; Lanxiao Shen; Yi Chen; Huafang Su
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.